Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016)
Prothena Corp Public (PRTA) posted Interest & Investment Income of $277,000 for Q1 2016, up 965.4% from $26,000 a year earlier and up 246.3% from the prior quarter.
Powered by 
Analysis
Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016) Analysis & Trends
For the trailing twelve months through Mar 31, 2016, Interest & Investment Income at Prothena Corp Public was $447,000, up 419.8% year-over-year; for FY2015, it was $196,000, up 148.1% from FY2014.
- Annual Interest & Investment Income shows a three-year compound annual growth rate of 239.7% (FY2012 to FY2015).
- In prior years, Prothena Corp Public's Interest & Investment Income was $79,000 in FY2014 (+11.3%), $71,000 in FY2013 and $5,000 in FY2012.
- The Q1 2016 figure stands as the highest quarterly Interest & Investment Income in data going back to Q4 2012.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last eight quarters, with growth averaging 200.6% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q1 2016, with growth of 965.4%; the weakest was Q1 2014, with a decline of 13.6%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $80,000 (Q4 2015), $50,000 (Q3 2015) and $40,000 (Q2 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Prothena Corp Public | 432.58 Mn | -823.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 277,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Sep 30, 2015 | 50,000.00 |
| Jun 30, 2015 | 40,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 25,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 16,000.00 |
| Mar 31, 2014 | 19,000.00 |
| Dec 31, 2013 | 21,000.00 |
| Sep 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Dec 31, 2012 | 5,000.00 |
API Access
Prothena Corp Public Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PRTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "PRTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PRTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();